等待開盤 07-21 09:30:00 美东时间
-0.250
-7.67%
Qualigen shares are trading higher after the company announced it was granted p...
07-16 23:16
Qualigen Therapeutics ( ($QLGN) ) has issued an announcement. On July 16, 2025,...
07-16 21:44
Qualigen Therapeutics, Inc. announced the grant of patents for its drug QN-302 in over 20 European countries, as well as in India, China, and Russia, with coverage extending into 2040. The patents, titled “Substituted Naphthalene Diimides and Their Use,” were developed by Professor Stephen Neidle and his team at University College London and licensed by Qualigen. CEO Kevin Richardson emphasized that the global patent coverage strengthens Qualigen...
07-16 12:00
Gainers ENDRA Life Sciences (NASDAQ:NDRA) stock increased by 50.4% to $5.2 dur...
07-08 05:06
Qualigen Therapeutics ( ($QLGN) ) just unveiled an update. On June 20, 2025, Qu...
06-24 23:48
Qualigen Therapeutics ( ($QLGN) ) has issued an announcement. On May 19, 2025, ...
05-20 05:48
Qualigen Therapeutics (NASDAQ:QLGN) announced on Monday that it received an expected deficiency notification letter from Nasdaq. The notice indicated that the Nasdaq Hearings Panel will consider the c...
05-20 05:35
The latest update is out from Qualigen Therapeutics ( ($QLGN) ). Qualigen Thera...
05-02 05:02
Qualigen Therapeutics ( ($QLGN) ) has released a notification of late filing. Q...
04-01 20:22
Shares of Qualigen Therapeutics (NASDAQ:QLGN) fell 21% on Tuesday following news that the company plans to participate in a funding round for Israeli medtech NanoSynex. The Carlsbad, Calif.-based onco...
01-29 06:48